Sandoz to invest $90M in Slovenia site that will produce biosimilars
Sandoz is investing $90 million to build a biosimilar development center in Ljubljana, Slovenia, the second major investment that the generics maker has made in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
